In observance of Independence Day in the U.S., CenterWatch Weekly will not be published Monday, July 4. The next issue will be published Monday, July 11. Read More
Among the many voices involved in the ongoing discussion about increasing diversity in clinical trials, one group has received less attention from sponsors, sites and regulators alike: transgender and nonbinary people. More effort needs to go into including these populations, according to one transgender advocate, including staff site training and special accommodations. Read More
Newly released data from a study on the costs and benefits of decentralized trials (DCT) demonstrate in hard numbers that using DCT methods can gain a sponsor or site as much as 25 times the original investment and score performance improvements in several areas. Read More
Under a new five-year action plan for accelerating the development of treatments for rare neurodegenerative diseases, the FDA will focus on incorporating new technologies and innovative trial approaches beginning with the study of amyotrophic lateral sclerosis (ALS). Read More
Novartis has committed $17.7 million to establish clinical trial centers at three historically black medical schools in an effort to help increase diversity, equity and inclusion in clinical research. Read More
The FDA’s Center for Biologics Evaluation and Research (CBER) has issued an updated agenda of guidances it intends to publish this year, indicating there are still two clinical research documents the center intends to address by the end of the year. Read More
